Patent ID: 9161906
Filing Date: 2015-10-20
Classification: A61K,A61P

Abstract:
1. A pharmaceutical composition for ophthalmic use, said composition comprising a phospholipid component composed of zwitterionic egg yolk phospholipids and an oily component consisting of one or more oils of essentially natural origin, and free of any synthetic oil or mineral oil, wherein the weight ratio of the oily component to the phospholipid component is in the range of 4:1 to 1:1, the phospholipid component is present from 0.1%-5% by weight, and the oily component is present from 0.3%-15% by weight, and a buffer with low ionic force in an amount sufficient to maintain the pH of the finished product in the range of 6.5-8, said buffer being selected from the group consisting of histidine and Tris and combinations thereof, to maintain stability of the composition.